Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Insight Molecular Diagnostics (IMDX) Non-cash Items (2017 - 2026)

Insight Molecular Diagnostics' Non-cash Items history spans 5 years, with the latest figure at $8.5 million for Q4 2025.

On a quarterly basis, Non-cash Items changed N/A to $8.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $8.5 million, a N/A change, with the full-year FY2025 number at $8.5 million, changed N/A from a year prior.
Non-cash Items hit $8.5 million in Q4 2025 for Insight Molecular Diagnostics, up from $306000.0 in the prior quarter.
Over the last five years, Non-cash Items for IMDX hit a ceiling of $19.1 million in Q4 2021 and a floor of $51.0 in Q2 2024.
Historically, Non-cash Items has averaged $3.6 million across 3 years, with a median of $292500.0 in 2025.
The widest YoY moves for Non-cash Items: up 764605.88% in 2025, down 33.62% in 2025.
Tracing IMDX's Non-cash Items over 3 years: stood at $19.1 million in 2021, then plummeted by 98.8% to $229000.0 in 2024, then surged by 3627.95% to $8.5 million in 2025.
Business Quant data shows Non-cash Items for IMDX at $8.5 million in Q4 2025, $306000.0 in Q3 2025, and $390000.0 in Q2 2025.